{"doi":"10.3389/frph.2021.657728","title":"A Landscape Analysis of Offering HIV Testing Services Within Family Planning Service Delivery","abstract":"Introduction: Offering HIV testing services (HTS) within sexual and reproductive health (SRH) services is a priority, especially for women who have a substantial risk. To reach women with HIV who do not know their status and prevent mother-to-child HIV transmission, the World Health Organization (WHO) recommends routinely offering HTS as part of family planning (FP) service delivery in high HIV burden settings. We conducted a landscape analysis to assess HTS uptake and HIV positivity in the context of FP/SRH services. Assessment of Research and Programs: We searched records from PubMed, four gray literature databases, and 13 organization websites, and emailed 24 organizations for data on HTS in FP/SRH services. We also obtained data from International Planned Parenthood Federation (IPPF) affiliates in Eswatini, Kenya, Lesotho, Malawi, Namibia, Uganda, Zambia, and Zimbabwe. Unique programs/studies from records were included if they provided data on, or barriers/facilitators to, offering HTS in FP/SRH. Overall, 2,197 records were screened and 12 unique programs/studies were eligible, including 10 from sub-Saharan Africa. Four reported on co-delivery of SRH services (including FP), with reported HTS uptake between 17 and 94%. Six reported data on HTS in FP services: four among general FP clients; one among couples; and one among female sex workers, adolescent girls, and young women. Two of the six reported HTS uptake >50% (51%, 419/814 Kenya; 63%, 5,930/9,439 Uganda), with positivity rates of 2% and 4.1%, respectively. Uptake was low (8%, 74/969 Kenya) in the one FP program offering pre-exposure prophylaxis. In the IPPF program, seven countries reported HTS uptake in FP services and ranged from 4% in Eswatini to 90% in Lesotho; between 0.6% (Uganda) and 8% (Eswatini) of those tested were HIV positive. Implications: Data on providing HTS in FP/SRH service delivery were sparse and HTS uptake varied widely across programs. Actionable Recommendations: As countries expand HTS in FP/SRH appropriate to epidemiology, they should ensure data are reported and monitored for progress and impact.","journal":"Frontiers in Reproductive Health","year":2021,"id":203506,"datarank":0.0,"base_score":0.0,"endowment":0.0,"self_citation_contribution":0.0,"citation_network_contribution":0.0,"self_endowment_contribution":0.0,"citer_contribution":0.0,"corpus_percentile":null,"corpus_rank":null,"citation_count":5,"citer_count":0,"citers_with_citation_signal":0,"citers_with_endowment":0,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":0.9519,"is_data_producer":false,"deposit_databanks":null,"is_oa":true,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":"2021-01-01","fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":676872,"name":"Caitlin Quinn","orcid":"0000-0001-5989-7172","position":1,"is_corresponding":false},{"id":784735,"name":"Nancy Kidula","orcid":"0000-0002-3447-244X","position":2,"is_corresponding":false},{"id":784736,"name":"Euphemia Sibanda","orcid":"0000-0003-1754-1076","position":3,"is_corresponding":false},{"id":784737,"name":"Petrus S. Steyn","orcid":"0000-0001-8300-7985","position":4,"is_corresponding":false},{"id":315407,"name":"Magdalena Barr‐DiChiara","orcid":"0000-0002-7404-7843","position":5,"is_corresponding":false},{"id":315408,"name":"Muhammad S. Jamil","orcid":"0000-0001-9637-7838","position":6,"is_corresponding":false},{"id":785273,"name":"Michelle Rodolph","orcid":null,"position":7,"is_corresponding":false},{"id":743383,"name":"Mary E. Gaffield","orcid":"0009-0004-4614-4314","position":8,"is_corresponding":false},{"id":366536,"name":"James Kiarie","orcid":"0000-0003-4180-7858","position":9,"is_corresponding":false},{"id":299049,"name":"Rachel Baggaley","orcid":"0000-0001-6320-3444","position":10,"is_corresponding":false},{"id":315409,"name":"Cheryl Johnson","orcid":"0000-0001-5499-5523","position":11,"is_corresponding":false},{"id":315410,"name":"Alison L. Drake","orcid":"0000-0002-4178-7706","position":0,"is_corresponding":true}],"reference_count":26,"raw_metadata":null,"created_at":"2026-07-18T23:51:18.050175Z","pmid":"36304029","pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}